Skip to content
Home/Companies/Biotech/Vetbiolix
Vetbiolix

Vetbiolix

Biotech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Vetbiolix?

Vetbiolix is a French Biotech company, currently owned by Finorpa Gestion since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Finorpa Gestion
Investor
Finorpa Gestion
Captech Sante · 2022 · Life Sciences VC

Key facts

HQFrance
SectorBiotech
Websitewww.vetbiolix.com

More from Captech Sante

Other portfolio companies in the same fund.

Genoskin
Genoskin
Active
BiotechFrance· 2024
Nutriearth
Nutriearth
Active
FoodTechFrance· 2024
Vaxinano
Vaxinano
Active
BiotechFrance· 2024
Verley
Verley
Active
FoodTechFrance· 2023
Hemerion
Hemerion
Active
MedTechFrance· 2022
Lattice Medical
Lattice Medical
Active
MedTechFrance· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Vetbiolix?

Vetbiolix is currently owned by Finorpa Gestion, through Captech Sante, since 2022.

When did Finorpa Gestion acquire Vetbiolix?

Finorpa Gestion acquired Vetbiolix in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue